Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
Santoni M, Romagnoli E, Saladino T, Foghini L, Guarino S, Capponi M, Giannini M, Cognigni PD, Ferrara G, Battelli N. Santoni M, et al. Among authors: battelli n. Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):78-84. doi: 10.1016/j.bbcan.2017.10.007. Epub 2017 Nov 7. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29126881 Review.
[Paraneoplastic syndromes: a review].
Berardi R, Grilli G, Romagnoli E, Saladino T, Freddari F, Tamburrano T, Galizia E, Carbonari G, Mariani C, Braconi C, Pierantoni C, Battelli N, Scartozzi M, Cascinu S. Berardi R, et al. Among authors: battelli n. Clin Ter. 2005 Nov-Dec;156(6):281-8. Clin Ter. 2005. PMID: 16463565 Review. Italian.
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients.
Pistelli M, De Lisa M, Ballatore Z, Caramanti M, Pagliacci A, Battelli N, Ridolfi F, Santoni M, Maccaroni E, Bracci R, Santinelli A, Biscotti T, Berardi R, Cascinu S. Pistelli M, et al. Among authors: battelli n. BMC Cancer. 2015 Mar 28;15:195. doi: 10.1186/s12885-015-1204-2. BMC Cancer. 2015. PMID: 25884918 Free PMC article.
Immune checkpoint inhibitors for metastatic bladder cancer.
Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A. Massari F, et al. Among authors: battelli n. Cancer Treat Rev. 2018 Mar;64:11-20. doi: 10.1016/j.ctrv.2017.12.007. Epub 2018 Jan 31. Cancer Treat Rev. 2018. PMID: 29407369 Review.
Durvalumab in Stage III Non-Small-Cell Lung Cancer.
Santoni M, Battelli N, Buti S. Santoni M, et al. Among authors: battelli n. N Engl J Med. 2018 Mar 1;378(9):869. doi: 10.1056/NEJMc1716426. N Engl J Med. 2018. PMID: 29504721 No abstract available.
Tivozanib for the treatment of renal cell carcinoma.
Santoni M, Massari F, Piva F, Carrozza F, Di Nunno V, Cimadamore A, Martignetti A, Montironi R, Battelli N. Santoni M, et al. Among authors: battelli n. Expert Opin Pharmacother. 2018 Jun;19(9):1021-1025. doi: 10.1080/14656566.2018.1480722. Epub 2018 May 31. Expert Opin Pharmacother. 2018. PMID: 29851529
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.
Santoni M, Massari F, Di Nunno V, Conti A, Cimadamore A, Scarpelli M, Montironi R, Cheng L, Battelli N, Lopez-Beltran A. Santoni M, et al. Among authors: battelli n. Drugs Context. 2018 Jun 5;7:212528. doi: 10.7573/dic.212528. eCollection 2018. Drugs Context. 2018. PMID: 29899754 Free PMC article.
114 results